Skip to main content

Inmune Bio, Inc 10-Q for FY2022 Q3

Inmune Bio, Inc. (INMB)

10-Q 2022-11-02 For: 2022-09-30
View Original
Added on April 07, 2026

About this 10-Q

Inmune Bio, Inc filed this 10-Q on November 2, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).

Headline figures

Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$98K
up 600.0% from $14K a year earlier
Net loss
$7.73M
compared with a net loss of $9.46M a year earlier
Diluted EPS
-$0.43
compared with -$0.55 a year earlier